CSTL
Castle Biosciences, Inc.
NASDAQHealthcareMedical - Diagnostics & ResearchUS
Rating:B-
Company Profile
CEO
Derek J. Maetzold
IPO Date
2019-07-25
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
Castle Biosciences, Inc.
CEO
Derek J. Maetzold
IPO Date
2019-07-25
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
| 550 |
| $22.92 |
| 16 Jul 2026 | MAETZOLD DEREK J | director, officer: Pres. & Chief Exec. Officer | S-Sale | Disposed | 1,357 | $22.92 |
| 16 Jul 2026 | MAETZOLD DEREK J | director, officer: Pres. & Chief Exec. Officer | S-Sale | Disposed | 1,153 | $22.92 |
| 16 Jul 2026 | MAETZOLD DEREK J | director, officer: Pres. & Chief Exec. Officer | S-Sale | Disposed | 278 | $22.92 |
| 16 Jul 2026 | MAETZOLD DEREK J | director, officer: Pres. & Chief Exec. Officer | M-Exempt | Disposed | 550 | $2.39 |
| 6 Jul 2026 | MAETZOLD DEREK J | director, officer: Pres. & Chief Exec. Officer | M-Exempt | Acquired | 6,214 | $2.39 |
| 6 Jul 2026 | MAETZOLD DEREK J | director, officer: Pres. & Chief Exec. Officer | S-Sale | Disposed | 6,214 | $24.29 |
| 6 Jul 2026 | MAETZOLD DEREK J | director, officer: Pres. & Chief Exec. Officer | S-Sale | Disposed | 1,357 | $24.29 |
| 6 Jul 2026 | MAETZOLD DEREK J | director, officer: Pres. & Chief Exec. Officer | S-Sale | Disposed | 1,153 | $24.29 |
| $1,001 - $15,000 |